Abstract | BACKGROUND/AIM: YKL-40 plays a role in proliferation and differentiation of malignant cells. The aim of this study was to examine whether YKL-40 is expressed in cutaneous squamous cell carcinoma (SCC). MATERIALS AND METHODS: The study was based on histologically-confirmed biopsies of cutaneous SCCs obtained from 38 patients. The tissue expression of YKL-40 was assessed using an immunohisto-chemical method. The percentage of cells showing a positive reaction as well as the intensity of the IHC reaction was assessed using the immunoreactive score developed by Remmele and Stegner. RESULTS: All samples of cutaneous SCCs showed cytoplasmic expression of YKL-40. The intensity of YKL-40 expression varied between 1 and 8 points, according to the applied scale. In the majority of cancers about 10-80% of tumor cells were positive for YKL-40. The intensity of the reaction was low (20 samples, 52.6%) or medium (18 samples, 47.4%). CONCLUSION: YKL-40 is expressed in cutaneous SCC. Further research is needed to establish the value of YKL-40 for diagnosis and monitoring of SCC.
|
Authors | Joanna Salomon, Aleksandra Piotrowska, Łukasz Matusiak, Piotr Dzięgiel, Jacek C Szepietowski |
Journal | Anticancer research
(Anticancer Res)
Vol. 38
Issue 8
Pg. 4753-4758
(Aug 2018)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 30061245
(Publication Type: Journal Article)
|
Copyright | Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- CHI3L1 protein, human
- Chitinase-3-Like Protein 1
|
Topics |
- Biomarkers, Tumor
(biosynthesis, blood)
- Carcinoma, Squamous Cell
(pathology)
- Chitinase-3-Like Protein 1
(biosynthesis, blood)
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
(methods)
- Retrospective Studies
- Skin Neoplasms
(pathology)
|